These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16887972)

  • 1. Type 2 cytotoxic T lymphocytes modulate the activity of dendritic cells toward type 2 immune responses.
    Iezzi G; Boni A; Degl'Innocenti E; Grioni M; Bertilaccio MT; Bellone M
    J Immunol; 2006 Aug; 177(4):2131-7. PubMed ID: 16887972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo persistence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines.
    Cerwenka A; Carter LL; Reome JB; Swain SL; Dutton RW
    J Immunol; 1998 Jul; 161(1):97-105. PubMed ID: 9647212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8 T cells inhibit IgE via dendritic cell IL-12 induction that promotes Th1 T cell counter-regulation.
    Thomas MJ; Noble A; Sawicka E; Askenase PW; Kemeny DM
    J Immunol; 2002 Jan; 168(1):216-23. PubMed ID: 11751965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged exposure of dendritic cells to maturation stimuli favors the induction of type-2 cytotoxic T lymphocytes.
    Boni A; Iezzi G; Degl'Innocenti E; Grioni M; Jachetti E; Camporeale A; Bellone M
    Eur J Immunol; 2006 Dec; 36(12):3157-66. PubMed ID: 17111344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity.
    Kemp RA; Ronchese F
    J Immunol; 2001 Dec; 167(11):6497-502. PubMed ID: 11714817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6 production by pulmonary dendritic cells impedes Th1 immune responses.
    Dodge IL; Carr MW; Cernadas M; Brenner MB
    J Immunol; 2003 May; 170(9):4457-64. PubMed ID: 12707321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene.
    Ankathatti Munegowda M; Xu S; Freywald A; Xiang J
    Mol Immunol; 2012 Jun; 51(2):143-9. PubMed ID: 22424785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of tumor-reactive type 1 and type 2 CD8+ T cell subpopulations in established pulmonary metastases.
    Dobrzanski MJ; Reome JB; Dutton RW
    J Immunol; 1999 Jun; 162(11):6671-80. PubMed ID: 10352285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40-ligated dendritic cells effectively expand melanoma-specific CD8+ CTLs and CD4+ IFN-gamma-producing T cells from tumor-infiltrating lymphocytes.
    Terheyden P; Straten P; Bröcker EB; Kämpgen E; Becker JC
    J Immunol; 2000 Jun; 164(12):6633-9. PubMed ID: 10843723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma.
    Fowler DH; Gress RE
    Leuk Lymphoma; 2000 Jul; 38(3-4):221-34. PubMed ID: 10830730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation.
    Ye Z; Tang C; Xu S; Zhang B; Zhang X; Moyana T; Yang J; Xiang J
    Cell Mol Immunol; 2007 Aug; 4(4):277-85. PubMed ID: 17764618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-4 blocks TH1-polarizing/inflammatory cytokine gene expression during monocyte-derived dendritic cell differentiation through histone hypoacetylation.
    López-Bravo M; Minguito de la Escalera M; Domínguez PM; González-Cintado L; del Fresno C; Martín P; Martínez del Hoyo G; Ardavín C
    J Allergy Clin Immunol; 2013 Dec; 132(6):1409-19. PubMed ID: 24139608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8alpha+ and CD11b+ dendritic cell-restricted MHC class II controls Th1 CD4+ T cell immunity.
    Lemos MP; Fan L; Lo D; Laufer TM
    J Immunol; 2003 Nov; 171(10):5077-84. PubMed ID: 14607905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparate cytotoxic activity of nickel-specific CD8+ and CD4+ T cell subsets against keratinocytes.
    Traidl C; Sebastiani S; Albanesi C; Merk HF; Puddu P; Girolomoni G; Cavani A
    J Immunol; 2000 Sep; 165(6):3058-64. PubMed ID: 10975816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function.
    Mailliard RB; Son YI; Redlinger R; Coates PT; Giermasz A; Morel PA; Storkus WJ; Kalinski P
    J Immunol; 2003 Sep; 171(5):2366-73. PubMed ID: 12928383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide modulation of dendritic cells is insufficient to mature dendritic cells to generate CTLs from naive polyclonal CD8+ T cells in vitro, whereas CD40 ligation is essential.
    Kelleher M; Beverley PC
    J Immunol; 2001 Dec; 167(11):6247-55. PubMed ID: 11714787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholera toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating dendritic cell activation.
    Lavelle EC; McNeela E; Armstrong ME; Leavy O; Higgins SC; Mills KH
    J Immunol; 2003 Sep; 171(5):2384-92. PubMed ID: 12928385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Th2 responses and allergic inflammation through bystander activation of CD8+ T lymphocytes in early life.
    Dubois A; Deruytter N; Adams B; Kanda A; Delbauve S; Fleury S; Torres D; François A; Pétein M; Goldman M; Dombrowicz D; Flamand V
    J Immunol; 2010 Jul; 185(2):884-91. PubMed ID: 20562264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses.
    Dobrzanski MJ; Reome JB; Hollenbaugh JA; Dutton RW
    J Immunol; 2004 Feb; 172(3):1380-90. PubMed ID: 14734713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell-intrinsic expression of NF-kappa B1 is required to promote optimal Th2 cell differentiation.
    Artis D; Kane CM; Fiore J; Zaph C; Shapira S; Joyce K; Macdonald A; Hunter C; Scott P; Pearce EJ
    J Immunol; 2005 Jun; 174(11):7154-9. PubMed ID: 15905559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.